Case Name: SALIX PHARMACEUTICALS, LTD. STOCKHOLDER LITIGATION Roberta Feinstein and Rex Gonsalves, Plaintiffs Below Appellants, v. John F. Chappell, Thomas W. D'Alonzo, William P. Keane, Mark A. Sirgo, Valeant Pharmaceuticals International, Inc., Valeant Pharmaceuticals International, and Sun Merger Sub, Inc., Defendants Below, Appellees.
Court: Delaware Court of Errors and Appeals
Jurisdiction: Delaware
Decision Date: 2017-01-26
Citations: 155 A.3d 832
Docket Number: No. 308, 2016
Parties: SALIX PHARMACEUTICALS, LTD. STOCKHOLDER LITIGATION
Judges: 
Reporter: West's Atlantic Reporter, Third Series
Volume: 155
Pages: 832–832

Head Matter:
SALIX PHARMACEUTICALS, LTD. STOCKHOLDER LITIGATION
Roberta Feinstein and Rex Gonsalves, Plaintiffs Below Appellants,
v.
John F. Chappell, Thomas W. D'Alonzo, William P. Keane, Mark A. Sirgo, Valeant Pharmaceuticals International, Inc., Valeant Pharmaceuticals International, and Sun Merger Sub, Inc., Defendants Below, Appellees.
No. 308, 2016
Supreme Court of Delaware.
Submitted: January 25, 2017
Decided: January 26, 2017
ORDER

Opinion:
Leo E. Strine, Jr., Chief Justice
This 26th day of January 2017, it appears to the Court that the judgment of the Court of Chancery should be affirmed for the reasons stated in its May 19, 2016 bench ruling.
NOW, THEREFORE, IT IS ORDERED that the judgment of the Court of Chancery is hereby AFFIRMED.